-
Maintaining Orphan Drug Status at the Time of Drug Approval in European Economic Area (EEA): European Union (EU) Plus Iceland and Norway From 2015 to 2025
Sep 9, 2025, 16:22 PM -
From Cost Containment to Modernization: Market Access Updates Across the EU4 and the UK in 2025
Sep 9, 2025, 16:22 PM -
Can Generative AI Automate Health Economic Model Verification?
Sep 9, 2025, 16:22 PM -
Human Alignment on Evaluating LLMs for Literature Review Extraction
Sep 9, 2025, 16:22 PM -
Evaluating the Costs of Perioperative Iron-Deficiency Anemia Management in China: A Comparison of Ferric Derisomaltose, Ferric Carboxymaltose, and Usual Care
Sep 9, 2025, 16:22 PM -
Overview of Hospital Management of Patients Treated With Thoracic Endovascular Repair (TEVAR) and Revascularization of the Left Subclavian Artery in France Based on the PMSI
Sep 9, 2025, 16:22 PM -
How Much Time Does Artificial Intelligence Really Save in Evidence Synthesis? A Systematic Literature Review
Sep 9, 2025, 16:22 PM -
Economic Burden of Pneumococcal Disease—Impact of Age and Underlying Medical Conditions
Sep 9, 2025, 16:22 PM -
Pricing Implications of Subcutaneous Reformulations Following Intravenous Launches: A Multicountry Analysis
Sep 9, 2025, 16:22 PM -
Analysis of HTA Decisions in Five European Countries for High Medical Need Products Approved by EMA
Sep 9, 2025, 16:22 PM -
Cross-Sectional Cohort Design Offers an Efficient Alternative to Prospective Cohort Design in Real-World Studies (RWS)
Sep 9, 2025, 16:22 PM -
The Incidence, Mortality, and Survival of Metastatic Colorectal Cancer (CRC) per TNM Stages in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2018-2022 Database Analysis
Sep 9, 2025, 16:22 PM -
Health-Related Quality of Life (HRQoL) Impacts in Individuals With Hypophosphatasia (HPP): A Systematic Literature Review (SLR)
Sep 9, 2025, 16:22 PM -
Treatment Patterns and Healthcare Costs of Newly Diagnosed Type 1 Diabetes Patients: A Retrospective Real-World Study of Hospital Care in Tianjin, China
Sep 9, 2025, 16:22 PM -
Clinical Expert Opinion on the Impact of Vosoritide on Health and Function in Children With Achondroplasia
Sep 9, 2025, 16:22 PM -
Outcome Measures Relevant for Assessing Health-Related Quality of Life and Utility in Primary Lateral Sclerosis (PLS)
Sep 9, 2025, 16:22 PM -
Budget Impact Models in CEESP Opinions: A Decade of Insights
Sep 9, 2025, 16:22 PM -
Health-Related Quality of Life in Patients Living With Osteosarcoma in Europe: A Systematic Review
Sep 9, 2025, 16:22 PM -
Cost-Effectiveness Analysis of Cariprazine vs. Risperidone for the Treatment of Schizophrenia With Predominantly Negative Symptoms (PNS) in United Arab Emirates
Sep 9, 2025, 16:22 PM -
Uncovering Patient Narratives of Opioid Use and Recovery Using Large Language Models for Topic and Emotion Analysis of Social Media Discussions
Sep 9, 2025, 16:22 PM
